6-(2-Aminopropyl)indole

6-(2-Aminopropyl)indole

Clinical data
Routes of administration	Oral
Legal status
Legal status	Uncontrolled (but covered under the Federal Analogue Act in the United States and Australia and likely under similar bills in other countries)
Identifiers
IUPAC name 1-(1H-Indol-6-yl)propan-2-amine
CAS Number	22196-72-1
PubChem CID	30999
ChemSpider	28759
Chemical and physical data
Formula	C11H14N2
Molar mass	174.24 g/mol
3D model (JSmol)	Interactive image
SMILES C1=C2C(=CC=C1CC(C)N([H])[H])C=C[N]2[H]
InChI InChI=1S/C11H14N2/c1-8(12)6-9-2-3-10-4-5-13-11(10)7-9/h2-5,7-8,13H,6,12H2,1H3 Y Key:QCFIFKAOUKPFPU-UHFFFAOYSA-N Y

6-(2-Aminopropyl)indole (6-API, 6-IT) is an indole derivative which was first identified being sold on the designer drug market by a laboratory in the Czech Republic in July 2016.^[1]

Alexander Shulgin says in his book TiHKAL "From the normal 3-position to the 2, the 4, the 5, the 6 or the 7-positions. All five alpha-methyltryptamine isomers are known, but only one is known to be active in man as a CNS active material. This is the 5-isomer, 5-(2-aminopropyl)indole or 5-IT".

Studies in dogs have also shown the drug to increase hemoglobin levels in the bloodstream.^[2]

Legality

• 6-API is a positional isomer of αMT, and as such may be covered by the analogue act in the USA (depending on the nature of its psychoactive effect).
• 6-API / 6-IT is illegal in the UK, as it was banned as a temporary class drug in June 2013, along with 9 other related compounds.^[3] On March 5, 2014 the UK Home Office announced that 6-API would be made a class B drug on 10 June 2014 alongside every other benzofuran entactogen and many structurally related drugs.^[4]
• 6-API is covered by the Australian analogue act as an analogue of MDA "by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures"^[5]

References